Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Chimeric Antigen Receptor (CAR) T-Cell and Other Immunotherapies (LOCAL 18) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 27, 2026 , from http://ppman.hank.ai/transparency/procedure/18/by-state?code_type=LOCAL
“Chimeric Antigen Receptor (CAR) T-Cell and Other Immunotherapies (LOCAL 18) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/18/by-state?code_type=LOCAL. Accessed
October 27, 2026 .
“Chimeric Antigen Receptor (CAR) T-Cell and Other Immunotherapies (LOCAL 18) by State,” HANK Price Transparency ,
accessed October 27, 2026 ,
http://ppman.hank.ai/transparency/procedure/18/by-state?code_type=LOCAL.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
LOCAL · across United States
18 — Chimeric Antigen Receptor (car) T-cell And Other Immunotherapies
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$900
National median
$900 – $36,749
IQR (p25 – p75)
3
hospitals filing
2
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 18 (LOCAL), with interquartile range
State Median p25 p75
CA $38,481 $37,711 $38,481
TX $900 $900 $900